High-yield points
- Shared cause: FGFR2 for both. Crouzon with acanthosis nigricans is FGFR3 .
- Hands:
- Apert has hand and foot syndactyly (middle three fingers always fused).
- Crouzon has normal limbs .
- Raised ICP: in Apert 83% by age 5 if managed expectantly, and recurs . Crouzon can present late as normocephalic pansynostosis .
- Hydrocephalus: common in Crouzon (about 23%), rare in Apert (2%). Most Apert ventriculomegaly is nonprogressive .
- Optic atrophy: Crouzon 28% vs Apert 8%, and Chiari predicts it .
- Sequence: posterior vault expansion first, then midface advancement in later childhood .
- Apert IQ: better with surgery before 1 year (50% vs 7% with IQ >70) .
- Pfeiffer:
- Hallmarks: broad thumbs and great toes, with the cloverleaf skull in type 2 (see caveats).
- Burden: about 9 operations per child.
- Airway: tracheostomy for types II and III.
- Chiari and hydrocephalus: acquired Chiari in 84%, hydrocephalus in 61%.
- Mortality: 7% (2 deaths at home) .
- Tracheal cartilaginous sleeve: found in 8 of 10 selected syndromic patients who had bronchoscopy; consider airway endoscopy .
- Muenke (FGFR3 P250R):
- Phenotype: coronal synostosis, often bilateral, or none.
- Hearing: low-frequency sensorineural loss in 95% of about 22 patients.
- Sex: females more often reported synostotic .
- Saethre–Chotzen (TWIST1):
- Phenotype: coronal synostosis, ptosis, small ears, 2–3 syndactyly.
- Surveillance: watch for raised ICP with yearly fundoscopy. Reoperation for ICP was 3 of 22 (14%) with tailored surgery at one center .
- Coronal synostosis without FGFR or TWIST1 variants: test TCF12 (10–20%) and EFNB1 .
Syndromic craniosynostosis combines suture fusion with characteristic facial, limb and systemic findings, usually from a single-gene variant. This topic covers the main syndromes a pediatric neurosurgeon meets:
- the FGFR2 syndromes: Crouzon, Apert and Pfeiffer;
- Muenke syndrome (FGFR3);
- Saethre–Chotzen syndrome (TWIST1);
- TCF12-related coronal synostosis;
- craniofrontonasal syndrome (EFNB1).
Surgical techniques are covered in the multisutural synostosis and monobloc topics.
Crouzon and Apert: at a glance
- Genetics:
- Both are usually caused by activating FGFR2 variants .
- A rarer variant, Crouzon syndrome with acanthosis nigricans, comes from FGFR3 variants and carries more choanal anomalies .
- Crouzon syndrome:
- Progressive craniofacial dysmorphology from premature suture fusion.
- Shallow orbits with proptosis, exposure keratopathy, strabismus and amblyopia.
- Midface hypoplasia with class III malocclusion and nasopharyngeal narrowing.
- Conductive or mixed hearing loss .
- No syndactyly.
- Apert syndrome:
- Multisuture synostosis (almost always coronal, usually also sagittal and lambdoid) and a retruded midface, with cleft palate in a subset.
- Syndactyly of the hands, always fusing the middle three fingers, with fusion of the second through fourth nails, plus syndactyly of the feet .
- Progressive fusion of other bones, including the cervical vertebrae .
- Skull shape: Apert gives a tall, narrow (turricephalic) vault, while Crouzon is more variable and moderately brachycephalic with bicoronal fusion .
- Progressive postnatal pansynostosis: Crouzon can present with a normal-looking head and late diagnosis, with signs of raised ICP. In a 17-patient series that included 4 Crouzon patients, diagnosis came at a mean of 63 months. Watch for a falling head-circumference percentile .
Neurosurgical problems
- Raised ICP:
- Present in 53% of Crouzon/Pfeiffer and 33% of Apert patients in a 167-patient series .
- In Apert managed expectantly, 83% developed raised ICP by age 5, and 35% had a recurrence .
- Hydrocephalus is far more common in Crouzon:
- Hydrocephalus needing treatment: 22.8% of Crouzon vs 2.0% of Apert. About 40% have ventriculomegaly that doesn't need treatment, and 85% of shunts needed revision .
- VP shunts were placed in 27% of Crouzon vs 16% of Apert in another series .
- Distinguish true hydrocephalus from nonprogressive ventriculomegaly, which is the majority in Apert .
- Chiari I: found in 47% of Crouzon/Pfeiffer patients with multisuture lambdoid involvement . It predicts optic atrophy .
- Vision: optic nerve atrophy developed in 27.9% of Crouzon vs 7.8% of Apert, at a mean age of 10 years . Ongoing ophthalmology is essential .
- Airway:
- Obstructive sleep apnea in 27–31% .
- In Apert, the airway can be obstructed at several levels, including tracheal anomalies .
- Airway obstruction itself can raise ICP .
- Cervical spine (Apert): take spine precautions because of cervical fusions .
Management
- Staged and multidisciplinary :
- Cranial vault expansion in late infancy, posterior and/or fronto-orbital.
- Midface advancement (Le Fort III or monobloc) in later childhood or adolescence for proptosis, airway and occlusion.
- Plus ophthalmology, audiology, orthodontics and sleep medicine.
- Posterior first: in Apert and Crouzon-Pfeiffer patients, occipital expansion as the first operation increased head circumference more (+1.09 vs +0.32 SD) and reduced papilledema and tonsillar herniation compared with fronto-orbital advancement . Distraction and springs are covered in Multisutural Synostosis.
- Burden of surgery: about 2 cranial expansions by skeletal maturity, with more in Pfeiffer .
- Midface advancement: after Le Fort III or monobloc at a median age of 7–8 years, vertical midface growth continued but forward growth was minimal, so later revision may be needed .
Development
- Crouzon: functional outcomes and life expectancy are generally good with coordinated care .
- Apert:
- Most have normal intelligence or mild intellectual disability, with moderate-to-severe disability in some .
- In one series, IQ was above 70 in 32%: in 50% of those operated before 1 year vs 7.1% operated later.
- Septum pellucidum anomalies and institutional care were associated with lower IQ, while callosal anomalies and ventricular size were not .
Pfeiffer syndrome
- What it is (see caveats):
- genetics: an FGFR craniosynostosis syndrome, from FGFR2 or, less often, FGFR1 variants;
- limbs: broad, medially deviated thumbs and great toes, with variable syndactyly;
- subtypes: type 1 (classic, milder), type 2 (cloverleaf skull, severe), type 3 (severe without cloverleaf).
- Severity and burden (28 patients over 17 years) :
- Subtypes: type I 61%, type II 25%, type III 14%.
- Surgery: about 9.3 operations per child (2.5 cranial vaults and 1.1 Le Fort III on average).
- Airway: tracheostomy was recommended for all type II and III patients.
- Chiari and hydrocephalus:
- acquired Chiari malformation in 84% (100% of types II and III);
- hydrocephalus requiring treatment in 61%;
- Chiari decompression in 50% of shunted patients, but in no patient treated by ETV.
- Ears: external auditory canal atresia in 59%.
- Mortality: 7% (2 deaths, both at home, away from surgery), lower than the 25–85% previously reported for severe subtypes.
- The authors' recommendations (to lower mortality further): early tracheostomy, pre-emptive tarsorrhaphy to protect vision, and regular MRI and sleep-study screening for Chiari.
- Classifying function rather than sutures (42 patients) :
- A functional classification: type A (mild), B (moderate), C (severe), scored on respiratory, ocular, otologic and neurologic problems.
- Who gained most: type C patients showed the greatest functional improvement after surgery.
- Suture pattern did not predict clinical severity.
- The airway beyond the face (10 of 27 syndromic patients who had bronchoscopy: 2 Crouzon, 3 Pfeiffer, 3 Apert, 1 Muenke, 1 Antley–Bixler) :
- Tracheal cartilaginous sleeve: found in 8 of these 10 selected patients. It is considered rare, with true incidence unknown.
- Implication: an under-recognized cause of morbidity and mortality that warrants airway endoscopy in symptomatic patients.
- Exorbitism (28 Crouzon–Pfeiffer patients, CT-based) :
- Orbits: small, and over-expanded by monobloc distraction to correct exorbitism.
- Growth: the orbit grows early and then arrests prematurely at 10–14 years, which aligns with delayed regression and secondary surgery after early monobloc (see the monobloc topic).
Muenke syndrome (FGFR3 p.Pro250Arg)
- Definition: the single FGFR3 variant c.749C>G (p.Pro250Arg) .
- Phenotype (highly variable) :
- Sutures: coronal synostosis, more often bilateral (brachycephaly) than unilateral (anterior plagiocephaly). Other sutures, pansynostosis, macrocephaly or no synostosis at all occur.
- Face: temporal bossing, widely spaced eyes, ptosis, mild midface retrusion.
- Other:
- hearing loss;
- developmental delay;
- carpal and tarsal fusions;
- broad thumbs and toes.
- Hearing: 95% of about 22 patients (9 evaluated plus 13 audiograms) had mild-to-moderate, low-frequency sensorineural hearing loss .
- Sex: among 321 reported cases, craniosynostosis was reported significantly more often in females (ascertainment bias possible) .
- Surgery (GeneReviews) :
- Timing: first repair, either fronto-orbital advancement at 3–6 months or endoscopic strip craniectomy before 3 months.
- Afterward: postoperative raised ICP and secondary contouring may occur.
- Practical point: test every child with coronal synostosis for FGFR3 P250R, which guides hearing follow-up and counseling (see caveats).
Saethre–Chotzen syndrome (TWIST1)
- Phenotype (GeneReviews) :
- Sutures: coronal synostosis (unilateral or bilateral) with facial asymmetry.
- Eyes: ptosis and strabismus.
- Ears: small ears with a prominent crus.
- Hands: variable 2–3 syndactyly of the hand.
- Cognition: usually normal, except with large deletions.
- Less common:
- parietal foramina;
- vertebral anomalies;
- raised ICP;
- obstructive sleep apnea.
- Surveillance :
- eyes: annual ophthalmology for papilledema;
- brain: imaging if ICP is suspected;
- hearing: audiology every 6–12 months;
- sleep: annual screening for sleep-disordered breathing.
- Reoperation for raised ICP (35 patients, patient-tailored surgery) :
- Sutures: varied, including unicoronal, bicoronal, sagittal and pansynostosis; 14.3% had no synostosis.
- Second surgery: in 9 of 22 (41%) patients managed from the start, but for raised ICP in only 3 (14%).
- Compare: up to 42% for raised ICP in the literature (not a controlled comparison).
- Complications: 7 of 26 operated patients (27%).
- Follow-up: long-term follow-up is advised.
Other genetic causes of coronal synostosis
- TCF12 (systematic review, 113 cases) :
- Prevalence: at least 2% of all craniosynostosis.
- Coronal cases: 10–20% of TWIST1- and FGFR-negative coronal synostosis, more in bicoronal and syndromic cases.
- Recommendation: coronal involvement should prompt TCF12 testing.
- Panel sequencing (309 patients: 233 with a negative FGFR1–3 hot-spot/TWIST1 screen and 76 tested prospectively) :
- Diagnostic yield for non-FGFR genes: 14–15%.
- Commonest genes: TCF12 (22) and EFNB1 (8), the latter craniofrontonasal syndrome.
- Others: ALX4, EFNA4, ERF and FGF10.
- Recommendation: include TCF12 and EFNB1 when testing nonsyndromic coronal synostosis or suspected TWIST1-negative Saethre–Chotzen.
- Craniofrontonasal syndrome (EFNB1):
- Phenotype: coronal synostosis with marked hypertelorism, a bifid nasal tip and grooved nails.
- Inheritance: X-linked, but females are more severely affected (see caveats).
- Practical point: genetic counseling is recommended for all craniosynostosis, and coronal involvement should prompt testing including TCF12 and EFNB1 . Its value for counseling on raised ICP, reoperation and hearing is reasoned rather than proven (see caveats).
Related topics
- Multisutural Synostosis: surgical techniques for syndromic pansynostosis.
- Monobloc Frontofacial Advancement: midface and fronto-orbital advancement.
- Coronal Synostosis: genetics and surgery of coronal fusion.
- Chiari I Malformation: hindbrain crowding in Crouzon and Pfeiffer.
- Ventriculomegaly vs Hydrocephalus: true hydrocephalus versus nonprogressive ventriculomegaly.
- Craniocerebral Disproportion: vault restriction and raised ICP.
- Anterior Cranial Vault Reconstruction (Fronto-Orbital Advancement): step-by-step procedure.
- Posterior Cranial Vault Reconstruction and Distraction: step-by-step procedure.
- Spring-Assisted Cranioplasty and Cranial Distraction: step-by-step procedure.
- Monobloc Frontofacial Advancement: Procedure: step-by-step procedure.
References
- Liampou E, Jain A, Howlader S, et al. Crouzon syndrome and craniosynostosis: a review for the twenty-first century. Cleft Palate Craniofac J 2026 (online ahead of print). doi:10.1177/10556656261475439. PMID 42671871. verified
- Wenger TL, Hing AV, Evans KN. Apert syndrome. In: Adam MP, et al, eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 2019 May 30. PMID 31145570. verified
- Delassus O, Ben Bouazza L, Traoré AR, et al. The influence of closed sutures on cranial morphology in Apert and Crouzon syndromes: a quantitative analysis. J Anat 2026;248(1):40–52. doi:10.1111/joa.70013. PMID 40624761. verified
- de Jong T, Bannink N, Bredero-Boelhouwer HH, et al. Long-term functional outcome in 167 patients with syndromic craniosynostosis; defining a syndrome-specific risk profile. J Plast Reconstr Aesthet Surg 2010;63(10):1635–1641. doi:10.1016/j.bjps.2009.10.029. PMID 19913472. verified
- Marucci DD, Dunaway DJ, Jones BM, et al. Raised intracranial pressure in Apert syndrome. Plast Reconstr Surg 2008;122(4):1162–1168. doi:10.1097/PRS.0b013e31818458f0. PMID 18827651. verified
- Wood BC, Oh AK, Keating RF, et al. Progressive postnatal pansynostosis: an insidious and pernicious form of craniosynostosis. J Neurosurg Pediatr 2015;16(3):309–316. doi:10.3171/2015.1.PEDS14464. PMID 26046691. verified
- Jönsson S, Nilsson D, Tarnow P, et al. Prevalence and treatment outcomes of hydrocephalus among children with craniofacial syndromes. J Plast Surg Hand Surg 2025;60:40–45. doi:10.2340/jphs.v60.42957. PMID 39976487. verified
- Fearon JA, Ditthakasem K, Harrison L, et al. Thirty-year experience treating syndromic craniosynostosis: long-term outcomes following cranial expansions. Plast Reconstr Surg 2025;155(1):131–137. doi:10.1097/PRS.0000000000011460. PMID 38589995. verified
- Fearon JA, Barrientos S, Ditthakasem K, et al. Optic nerve atrophy in syndromic craniosynostosis. Plast Reconstr Surg 2022;150(2):381e–386e. doi:10.1097/PRS.0000000000009367. PMID 35671456. verified
- Cuperus IE, van Veelen MC, Spoor JK, et al. Chiari malformation in syndromic and non-syndromic lambdoid craniosynostosis: a longitudinal cohort study. Plast Reconstr Surg 2026 (online ahead of print). doi:10.1097/PRS.0000000000012967. PMID 42024012. verified
- Spruijt B, Rijken BFM, den Ottelander BK, et al. First vault expansion in Apert and Crouzon-Pfeiffer syndromes: front or back? Plast Reconstr Surg 2016;137(1):112e–121e. doi:10.1097/PRS.0000000000001894. PMID 26368328. verified
- Renier D, Arnaud E, Cinalli G, et al. Prognosis for mental function in Apert's syndrome. J Neurosurg 1996;85(1):66–72. doi:10.3171/jns.1996.85.1.0066. PMID 8683284. verified
- Jayakumar NK, Pendem S, Vudatha RP, et al. Impact of Lefort III/monobloc advancement on midface growth in children with syndromic craniosynostosis: a systematic review. J Craniomaxillofac Surg 2025;53(5):568–575. doi:10.1016/j.jcms.2025.01.001. PMID 39915153. verified
- Khabyeh-Hasbani N, Lu YH, Baumgartner W, et al. Contemporary management of the upper limb in Apert syndrome: a review. Plast Reconstr Surg Glob Open 2024;12(8):e6067. doi:10.1097/GOX.0000000000006067. PMID 39148509. verified
- Fearon JA, Rhodes J. Pfeiffer syndrome: a treatment evaluation. Plast Reconstr Surg 2009;123(5):1560–1569. doi:10.1097/PRS.0b013e3181a2057e. PMID 19407629. verified
- Greig AV, Wagner J, Warren SM, et al. Pfeiffer syndrome: analysis of a clinical series and development of a classification system. J Craniofac Surg 2013;24(1):204–215. doi:10.1097/SCS.0b013e31826704be. PMID 23348287. verified
- Pickrell BB, Meaike JD, Cañadas KT, et al. Tracheal cartilaginous sleeve in syndromic craniosynostosis: an underrecognized source of significant morbidity and mortality. J Craniofac Surg 2017;28(3):696–699. doi:10.1097/SCS.0000000000003489. PMID 28468151. verified
- Way BLM, Khonsari RH, Karunakaran T, et al. Correcting exorbitism by monobloc frontofacial advancement in Crouzon-Pfeiffer syndrome: an age-specific, time-related, controlled study. Plast Reconstr Surg 2019;143(1):121e–132e. doi:10.1097/PRS.0000000000005105. PMID 30589795. verified
- Kruszka P, Rolle M, Kahle KT, Muenke M. Muenke syndrome. In: Adam MP, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–; updated 2023. PMID 20301588. verified
- Doherty ES, Lacbawan F, Hadley DW, et al. Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet A 2007;143A(24):3204–3215. doi:10.1002/ajmg.a.32078. PMID 18000976. verified
- Gallagher ER, Ratisoontorn C, Cunningham ML. Saethre-Chotzen syndrome. In: Adam MP, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–; updated 2019. PMID 20301368. verified
- Kurzbuch AR, Cooper B, Duncan C, et al. Patient tailored surgery in Saethre-Chotzen syndrome: analysis of reoperation for intracranial hypertension. J Craniofac Surg 2023;34(7):2099–2103. doi:10.1097/SCS.0000000000009429. PMID 37226293. verified
- Foss-Skiftesvik J, Larsen CC, Stoltze UK, et al. The role of pathogenic TCF12 variants in children with coronal craniosynostosis: a systematic review with addition of two novel cases. Childs Nerv Syst 2024;40(11):3655–3671. doi:10.1007/s00381-024-06544-z. PMID 39060747. verified
- Lee E, Le T, Zhu Y, et al. A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations. Genet Med 2018;20(9):1061–1068. doi:10.1038/gim.2017.214. PMID 29215649. verified
Verification:
- Original sections (2026-10-23): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract.
- Pfeiffer, Muenke, Saethre–Chotzen and other-gene sections, references 15–24 (2026-11-17): checked the same way.
- GeneReviews references 2, 19 and 21 were checked against their PubMed/Europe PMC summaries. Full texts were not reviewed.
- "No syndactyly" in Crouzon reflects that the Crouzon review lists no limb anomalies.
- "Later revision may be needed" after midface advancement is this text's inference from the growth data.
Caveats (added sections):
- The Pfeiffer genetics (FGFR2 or FGFR1), the broad thumbs and great toes, and the three clinical subtypes (cloverleaf skull in type 2) are standard teaching; the cited abstracts (15–18) use type I–III or A–C without defining them.
- References 17 and 18 include other syndromes or combine Crouzon and Pfeiffer.
- The following are standard teaching, not drawn from the cited abstracts:
- the craniofrontonasal phenotype and its paradoxical X-linked severity in females;
- the advice to test every coronal synostosis for FGFR3 P250R;
- the value of genetic results for counseling on raised ICP, reoperation and hearing.